Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2006-10-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on Escitalopram
NCT00707863
Beta-CIT-SPECT and Neurophysiology in Depression
NCT00145132
The Effects of Increased Central Serotonergic Activity on Information Processing
NCT00206934
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
NCT00183677
A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
NCT00703742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as usual
simultaneous EEG/fMRI
simultaneous EEG/fMRI
fMRI/EEG recordings
fMRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
simultaneous EEG/fMRI
fMRI/EEG recordings
fMRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for pharmacological treatment
Exclusion Criteria
* Neurological or severe somatic disorders
* Women during pregnancy or lactation
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
H. Lundbeck A/S
INDUSTRY
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oliver Pogarell
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrich Hegerl, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry, Ludwig-Maximilians-University
Oliver Pogarell, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry, Ludwig-Maximilians-University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry and Clin. Radiology, Ludwig-Maximilian-University
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005-003752-35
Identifier Type: -
Identifier Source: secondary_id
ESC_03082005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.